Role of Interleukin-1β and Prostaglandin E2 in Prediction and Outcome of Apnea in Neonates
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Banhā, Egypt
- Amany El-Rebigi
-
-
Al-Qalyubia
-
Cairo, Al-Qalyubia, Egypt, 13511
- Benha University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Preterm infants born at less than 37 weeks of gestation.
- Neonates aged from birth up to 28 days.
- Neonates diagnosed with apnea of prematurity or exhibiting apneic episodes
Exclusion Criteria:
- Full-term neonates.
- Neonates with major congenital malformations or genetic syndromes.
- Neonates with severe neurological impairments (e.g., intraventricular hemorrhage grade III or IV).
- Neonates with confirmed or suspected sepsis or active infections.
- Neonates receiving steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or other medications known to alter interleukin-1β or prostaglandin E2 levels.
- Neonates with congenital heart diseases.
- Neonates with a history of significant birth asphyxia requiring extensive resuscitation.
- Neonates whose parents or guardians refuse to provide informed consent.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Duration of NICU stay
Time Frame: 1 month
|
1 month
|
|
Mortality rate
Time Frame: 1 month
|
1 month
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MS 4-5-2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.